Public Profile

Virbac Corporation

Virbac Corporation, a leading player in the animal health industry, is headquartered in the United States and operates extensively across major global regions. Founded in 1964, Virbac has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of pets and livestock. The company offers a diverse range of core products, including vaccines, pharmaceuticals, and nutritional supplements, all designed to enhance animal health. What sets Virbac apart is its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a strong market position, Virbac has achieved notable milestones, including significant advancements in veterinary medicine and a robust global presence. As a result, it continues to be a preferred choice for veterinarians and pet owners alike, dedicated to improving the lives of animals worldwide.

DitchCarbon Score

How does Virbac Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Virbac Corporation's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Virbac Corporation's reported carbon emissions

Virbac Corporation, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the veterinary and pharmaceutical sectors are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for reducing greenhouse gas emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the value chain). As the industry evolves, Virbac Corporation may consider establishing measurable climate commitments to align with global sustainability goals and enhance its environmental stewardship.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Virbac Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Virbac Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Virbac Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ceva Sante Animale

FR
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Elanco

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Bayer

DE
Chemicals nec
Updated 10 days ago

Dechra

GB
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Boehringer Ingelheim (Canada) Ltd./Ltée.

CA
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

ZIVO Bioscience, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers